145 related articles for article (PubMed ID: 10725082)
1. Remission from lupus nephritis resistant to cyclophosphamide after additional treatment with cyclosporin A.
Ferrario L; Bellone M; Bozzolo E; Baldissera E; Sabbadini MG
Rheumatology (Oxford); 2000 Feb; 39(2):218-220. PubMed ID: 10725082
[No Abstract] [Full Text] [Related]
2. [Response to mycophenolate mofetil in a case of lupus nephropathy resistant to cyclophosphamide IV and cyclosporin A].
Navas-Parejo A; Espigares MJ; Alhosni A; García-Valdecasas J
Nefrologia; 2001; 21(5):516-7. PubMed ID: 11795027
[No Abstract] [Full Text] [Related]
3. Mycophenolate mofetil therapy for children with lupus nephritis refractory to both intravenous cyclosphosphamide and cyclosporine.
Fu YF; Liu GL
Clin Nephrol; 2001 Apr; 55(4):318-21. PubMed ID: 11334319
[TBL] [Abstract][Full Text] [Related]
4. [Cyclosporine A in treatment of lupus nephritis resistant to cyclophosphamide and mycophenolate mofetil: a case report].
Mellor-Pita S; Yebra Bango M; Tutor-Ureta P; Fernández J
Rev Clin Esp; 2006 Oct; 206(9):464-5. PubMed ID: 17042994
[No Abstract] [Full Text] [Related]
5. Mycophenolate mofetil for lupus nephritis.
McCune WJ
N Engl J Med; 2005 Nov; 353(21):2282-4. PubMed ID: 16306526
[No Abstract] [Full Text] [Related]
6. The treatment of lupus nephritis: revisiting Galen.
Lewis EJ
Ann Intern Med; 2001 Aug; 135(4):296-8. PubMed ID: 11511144
[No Abstract] [Full Text] [Related]
7. Induction therapy for active lupus nephritis: mycophenolate mofetil versus cyclophosphamide.
Burchardi C; Schlöndorff D
Nat Clin Pract Nephrol; 2006 Jun; 2(6):314-5. PubMed ID: 16932452
[No Abstract] [Full Text] [Related]
8. Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study.
Zavada J; Pesickova S; Rysava R; Olejarova M; Horák P; Hrncír Z; Rychlík I; Havrda M; Vítova J; Lukác J; Rovensky J; Tegzova D; Böhmova J; Zadrazil J; Hána J; Dostál C; Tesar V
Lupus; 2010 Oct; 19(11):1281-9. PubMed ID: 20605876
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of cyclosporin a neoral in the treatment of paediatric lupus nephritis with heavy proteinuria.
Fu LW; Yang LY; Chen WP; Lin CY
Br J Rheumatol; 1998 Feb; 37(2):217-21. PubMed ID: 9569080
[TBL] [Abstract][Full Text] [Related]
10. Low dose cyclosporine A in the treatment of resistant proliferative lupus nephritis.
Sheikholeslami M; Hajialilo M; Rasi Hashemi SS; Malek Mahdavi A; Gojazadeh M; Khabbazi A
Mod Rheumatol; 2018 May; 28(3):523-529. PubMed ID: 28753077
[TBL] [Abstract][Full Text] [Related]
11. Summaries for patients. Multitarget therapy for induction treatment of lupus nephritis.
Ann Intern Med; 2015 Jan; 162(1):I24. PubMed ID: 25383607
[No Abstract] [Full Text] [Related]
12. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis.
Karassa FB; Isenberg DA
N Engl J Med; 2001 Feb; 344(5):382-3. PubMed ID: 11195799
[No Abstract] [Full Text] [Related]
13. Short-term outcomes of induction therapy with tacrolimus versus cyclophosphamide for active lupus nephritis: A multicenter randomized clinical trial.
Chen W; Tang X; Liu Q; Chen W; Fu P; Liu F; Liao Y; Yang Z; Zhang J; Chen J; Lou T; Fu J; Kong Y; Liu Z; Fan A; Rao S; Li Z; Yu X
Am J Kidney Dis; 2011 Feb; 57(2):235-44. PubMed ID: 21177013
[TBL] [Abstract][Full Text] [Related]
14. Sequential therapies for proliferative lupus nephritis.
Gelber AC; Christopher-Stine L; Fine DM
N Engl J Med; 2004 Jun; 350(24):2518-20; author reply 2518-20. PubMed ID: 15195341
[No Abstract] [Full Text] [Related]
15. [Cyclosporin therapy of patients with systemic lupus erythematosus].
Gergely P
Orv Hetil; 1994 Nov; 135(47):2591-5. PubMed ID: 7824258
[TBL] [Abstract][Full Text] [Related]
16. Induction therapy for active lupus nephritis: mycophenolate mofetil is superior to cyclophosphamide.
Elliott JR; Manzi S
Nat Clin Pract Rheumatol; 2006 Jul; 2(7):354-5. PubMed ID: 16932717
[No Abstract] [Full Text] [Related]
17. Update on the management of lupus nephritis: let the treatment fit the patient.
Bertsias G; Boumpas DT
Nat Clin Pract Rheumatol; 2008 Sep; 4(9):464-72. PubMed ID: 18756272
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
Ginzler EM; Dooley MA; Aranow C; Kim MY; Buyon J; Merrill JT; Petri M; Gilkeson GS; Wallace DJ; Weisman MH; Appel GB
N Engl J Med; 2005 Nov; 353(21):2219-28. PubMed ID: 16306519
[TBL] [Abstract][Full Text] [Related]
19. Treatment of steroid-resistant membranous lupus nephritis with plasmapheresis and low-dose cyclosporine.
Fujinaga S; Ohtomo Y; Umino D; Mochizuki H; Takemoto M; Shimizu T; Yamashiro Y; Kaneko K
Pediatr Nephrol; 2007 Apr; 22(4):616-7. PubMed ID: 17115192
[No Abstract] [Full Text] [Related]
20. Could we abandon cyclophosphamide in systemic vasculitis and lupus nephritis?
Kallenberg CG
Ann Rheum Dis; 2013 Apr; 72 Suppl 2():ii62-5. PubMed ID: 23253917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
